226 related articles for article (PubMed ID: 7036812)
21. Susceptibility of current clinical isolates of Pseudomonas aeruginosa and enteric gram-negative bacilli to amikacin and other aminoglycoside antibiotics.
Dámaso D; Moreno-López M; Martínez-Beltrán J; García-Iglesias MC
J Infect Dis; 1976 Nov; 134 SUPPL():S394-90. PubMed ID: 825591
[TBL] [Abstract][Full Text] [Related]
22. Aminoglycoside resistance in clinical Escherichia coli and Klebsiella pneumoniae isolates from Western Norway.
Lindemann PC; Risberg K; Wiker HG; Mylvaganam H
APMIS; 2012 Jun; 120(6):495-502. PubMed ID: 22583362
[TBL] [Abstract][Full Text] [Related]
23. In vitro activity of aminoglycosides against clinical isolates of Acinetobacter baumannii complex and other nonfermentative Gram-negative bacilli causing healthcare-associated bloodstream infections in Taiwan.
Liu JY; Wang FD; Ho MW; Lee CH; Liu JW; Wang JT; Sheng WH; Hseuh PR; Chang SC
J Microbiol Immunol Infect; 2016 Dec; 49(6):918-923. PubMed ID: 26364729
[TBL] [Abstract][Full Text] [Related]
24. In vitro activity of plazomicin compared to other clinically relevant aminoglycosides in carbapenem-resistant Enterobacteriaceae.
Clark JA; Kulengowski B; Burgess DS
Diagn Microbiol Infect Dis; 2020 Oct; 98(2):115117. PubMed ID: 32755805
[TBL] [Abstract][Full Text] [Related]
25. [Comparison of bactericidal effects of four aminoglycoside antibiotics: amikacin, gentamicin, kanamycin and tobramycin (author's transl)].
Drugeon HB; Courtieu AL
Ann Microbiol (Paris); 1979 Apr; 130A(3):331-43. PubMed ID: 114083
[TBL] [Abstract][Full Text] [Related]
26. Serum sensitivity and cell surface hydrophobicity of Klebsiella pneumoniae treated with gentamicin, tobramycin and amikacin.
Hostacká A
J Basic Microbiol; 1998; 38(5-6):383-8. PubMed ID: 9871334
[TBL] [Abstract][Full Text] [Related]
27. Tobramycin, amikacin, sissomicin, and gentamicin resistant Gram-negative rods.
Drasar FA; Farrell W; Maskell J; Williams JD
Br Med J; 1976 Nov; 2(6047):1284-7. PubMed ID: 1000196
[TBL] [Abstract][Full Text] [Related]
28. Aminoglycoside Heteroresistance in Acinetobacter baumannii AB5075.
Anderson SE; Sherman EX; Weiss DS; Rather PN
mSphere; 2018 Aug; 3(4):. PubMed ID: 30111627
[TBL] [Abstract][Full Text] [Related]
29. The major aminoglycoside-modifying enzyme AAC(3)-II found in Escherichia coli determines a significant disparity in its resistance to gentamicin and amikacin in China.
Xiao Y; Hu Y
Microb Drug Resist; 2012 Feb; 18(1):42-6. PubMed ID: 22066787
[TBL] [Abstract][Full Text] [Related]
30. Association between the Presence of Aminoglycoside-Modifying Enzymes and In Vitro Activity of Gentamicin, Tobramycin, Amikacin, and Plazomicin against Klebsiella pneumoniae Carbapenemase- and Extended-Spectrum-β-Lactamase-Producing Enterobacter Species.
Haidar G; Alkroud A; Cheng S; Churilla TM; Churilla BM; Shields RK; Doi Y; Clancy CJ; Nguyen MH
Antimicrob Agents Chemother; 2016 Sep; 60(9):5208-14. PubMed ID: 27297487
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the in vitro activities of BB-K8 and three other aminoglycosides against 215 strains of Pseudomonas and Enterobacteriaceae with variable sensitivity to kanamycin and gentamicin.
Yourassowsky E; Schoutens E; Vanderlinden MP
Chemotherapy; 1975; 21(1):45-51. PubMed ID: 807457
[TBL] [Abstract][Full Text] [Related]
32. Appearance of amikacin and tobramycin resistance due to 4'-aminoglycoside nucleotidyltransferase [ANT(4')-II] in gram-negative pathogens.
Jacoby GA; Blaser MJ; Santanam P; Hächler H; Kayser FH; Hare RS; Miller GH
Antimicrob Agents Chemother; 1990 Dec; 34(12):2381-6. PubMed ID: 1965106
[TBL] [Abstract][Full Text] [Related]
33. In vitro activity of minocycline combined with aminoglycosides against Klebsiella pneumoniae carbapenemase-producing K. pneumoniae.
Wentao N; Guobao L; Jin Z; Junchang C; Rui W; Zhancheng G; Youning L
J Antibiot (Tokyo); 2018 May; 71(5):506-513. PubMed ID: 29416121
[TBL] [Abstract][Full Text] [Related]
34. Changes in resistance to aminoglycoside antibiotics of different bacterial strains isolated during the period 1978 to 1983. Netilmicin as alternative therapy.
Bovelacci A; Montini G; Ramacciotti PG
Chemioterapia; 1985 Dec; 4(6):439-44. PubMed ID: 3830413
[TBL] [Abstract][Full Text] [Related]
35. High-level resistance to gentamicin in clinical isolates of enterococci.
Mederski-Samoraj BD; Murray BE
J Infect Dis; 1983 Apr; 147(4):751-7. PubMed ID: 6404994
[TBL] [Abstract][Full Text] [Related]
36. [In vitro study of the synergistic effect of cefotiam- aminoglycoside combinations on strains of low susceptibility to this cephalosporin].
Husson MO; Izard D; Leclerc H
Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):466-8. PubMed ID: 3911141
[TBL] [Abstract][Full Text] [Related]
37. In vitro susceptibility of gentamicin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to aminoglycoside antibiotics.
Ramírez-Ronda CH; Nevárez M; Gutiérrez-Núñez JJ; Reyes Y
Bol Asoc Med P R; 1983 Jul; 75(7):305-7. PubMed ID: 6442865
[No Abstract] [Full Text] [Related]
38. Resistance to amikacin and isepamicin in rabbits with experimental endocarditis of an aac(6')-Ib-bearing strain of Klebsiella pneumoniae susceptible in vitro.
Caulin E; Coutrot A; Carbon C; Collatz E
Antimicrob Agents Chemother; 1996 Dec; 40(12):2848-53. PubMed ID: 9124853
[TBL] [Abstract][Full Text] [Related]
39. Determinants of resistance to various aminoglycoside antibiotics.
Pisano A; Mattina R; Nicoletti G
Antibiotica; 1977 Mar; 14(1):58-72. PubMed ID: 879719
[No Abstract] [Full Text] [Related]
40. Antimicrobial agents--Part II. The aminoglycosides: streptomycin, kanamycin, gentamicin, tobramycin, amikacin, neomycin.
Brewer NS
Mayo Clin Proc; 1977 Nov; 52(11):675-9. PubMed ID: 336988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]